{
  "id": "8511e67b5c8a6613",
  "title": "Lilly Expects Weight Loss Pill in 2Q",
  "description": "Eli Lilly Chief Financial Officer Lucas Montarce says their weight loss pill is on track to launch in the US in the second quarter, pending approval by the Food and Drug Administration. Montarce says they \u201cfeel good about the progress.\u201d He speaks to Katie Greifeld.",
  "content": "Eli Lilly Chief Financial Officer Lucas Montarce says their weight loss pill is on track to launch in the US in the second quarter, pending approval by the Food and Drug Administration. Montarce says they \u201cfeel good about the progress.\u201d He speaks to Katie Greifeld.",
  "source": "Bloomberg Markets",
  "source_url": "https://www.bloomberg.com/news/videos/2026-02-04/lilly-says-weight-loss-pill-on-track-for-2q-launch-in-us-video",
  "published_at": "2026-02-04T14:21:52+00:00",
  "fetched_at": "2026-02-05T00:29:17.336486+00:00",
  "category": "macroeconomics_finance",
  "subcategory": null,
  "keywords": [
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "Lilly Expects Weight Loss Pill in 2Q",
    "description": "Eli Lilly Chief Financial Officer Lucas Montarce says their weight loss pill is on track to launch in the US in the second quarter, pending approval by the Food and Drug Administration. Montarce says they \u201cfeel good about the progress.\u201d He speaks to Katie Greifeld.",
    "url": "https://www.bloomberg.com/news/videos/2026-02-04/lilly-says-weight-loss-pill-on-track-for-2q-launch-in-us-video",
    "published": "2026-02-04T14:21:52+00:00",
    "source": "Bloomberg Markets"
  }
}